Mindblown: a blog about philosophy.

Telomir Pharmaceuticals, a biotech company specializing in novel treatments for inflammatory diseases, announced today its initial public offering (IPO) aiming to raise $14 million. The Baltimore-based company, which was established in 2021, is focusing on the development of TELOMIR-1, an innovative oral therapy targeting essential metals in human stem cells. The company’s lead compound, TELOMIR-1, […]

Telomir Pharmaceuticals, a biotech company specializing in novel treatments for inflammatory diseases, announced today its initial public offering (IPO) aiming to raise $14 million. The Baltimore-based company, which was established in 2021, is focusing on the development of TELOMIR-1, an innovative oral therapy targeting essential metals in human stem cells. The company’s lead compound, TELOMIR-1, […]

Telomir Pharmaceuticals, a biotech company specializing in novel treatments for inflammatory diseases, announced today its initial public offering (IPO) aiming to raise $14 million. The Baltimore-based company, which was established in 2021, is focusing on the development of TELOMIR-1, an innovative oral therapy targeting essential metals in human stem cells. The company’s lead compound, TELOMIR-1, […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Inc., a biotech firm focusing on cellular therapies for neurodegenerative diseases, is facing a class action lawsuit filed by investors. The lawsuit alleges that the company made false and misleading statements between August 15, 2022, and September 27, 2023, violating Federal Securities Laws. These statements are said to have led to […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Inc., a biotech firm focusing on cellular therapies for neurodegenerative diseases, is facing a class action lawsuit filed by investors. The lawsuit alleges that the company made false and misleading statements between August 15, 2022, and September 27, 2023, violating Federal Securities Laws. These statements are said to have led to […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Inc., a biotech firm focusing on cellular therapies for neurodegenerative diseases, is facing a class action lawsuit filed by investors. The lawsuit alleges that the company made false and misleading statements between August 15, 2022, and September 27, 2023, violating Federal Securities Laws. These statements are said to have led to […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Inc., a biotech firm focusing on cellular therapies for neurodegenerative diseases, is facing a class action lawsuit filed by investors. The lawsuit alleges that the company made false and misleading statements between August 15, 2022, and September 27, 2023, violating Federal Securities Laws. These statements are said to have led to […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Inc., a biotech firm focusing on cellular therapies for neurodegenerative diseases, is facing a class action lawsuit filed by investors. The lawsuit alleges that the company made false and misleading statements between August 15, 2022, and September 27, 2023, violating Federal Securities Laws. These statements are said to have led to […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Inc., a biotech firm focusing on cellular therapies for neurodegenerative diseases, is facing a class action lawsuit filed by investors. The lawsuit alleges that the company made false and misleading statements between August 15, 2022, and September 27, 2023, violating Federal Securities Laws. These statements are said to have led to […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Inc., a biotech firm focusing on cellular therapies for neurodegenerative diseases, is facing a class action lawsuit filed by investors. The lawsuit alleges that the company made false and misleading statements between August 15, 2022, and September 27, 2023, violating Federal Securities Laws. These statements are said to have led to […]